CESSATION THERAPEUTICS, INC. — Form D
CESSATION THERAPEUTICS, INC. of Dallas, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-03
- Form: D
- Accession: 0001926434-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 2
- Date of first sale: 2024-03-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-509539
Issuer
- Name: CESSATION THERAPEUTICS, INC.
- CIK: 0001926434
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 12200 Stemmons Freeway, Dallas, TX, 75234
- Phone: 408-479-7843
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Daniel Fine | Director | Dallas, TX |
| John Harkey | Director | Dallas, TX |
| Mark Pearson | Director | Sugar Land, TX |
| Jay Shepard | Director | Dallas, TX |
| Sharon Tetlow | Director | San Francisco, CA |
| Andrew Barrett | Executive Officer | Dallas, TX |
| Mark Pearson | Executive Officer | Sugar Land, TX |
| Eric Rasmussen | Executive Officer | Vancouver, A1 |
| John Harkey | Executive Officer | Dallas, TX |
| David Genecov | Director | San Jose, CA |
Other filings by this issuer (1)
More